Global trends in rates of peritoneal dialysis.
Reads0
Chats0
TLDR
The number of patients treated with peritoneal dialysis rose worldwide from 1997 to 2008, with a 2.5-fold increase in the prevalence of peritoneAL dialysis patients in developing countries, and the proportion of all dialysis Patients treated with this modality continues to decline in developed countries.Abstract:
Although there is a perception that the use of peritoneal dialysis is declining worldwide, compilations of global data are unavailable to test this hypothesis. We assessed longitudinal trends in the use of peritoneal dialysis from 1997 to 2008 in 130 countries. The preferred data sources were renal registries, followed by nephrology societies, health ministries, academic centers, national experts, and industry affiliates. In 2008, there were approximately 196,000 peritoneal dialysis patients worldwide, representing 11% of the dialysis population. In total, 59% were treated in developing countries and 41% in developed countries. Over 12 years, the number of peritoneal dialysis patients increased in developing countries by 24.9 patients per million population and in developed countries by 21.8 per million population. The proportion of all dialysis patients treated with peritoneal dialysis did not change in developing countries but significantly declined in developed countries by 5.3%. The use of automated peritoneal dialysis increased by 14.5% in developing countries and by 30.3% in developed countries. In summary, the number of patients treated with peritoneal dialysis rose worldwide from 1997 to 2008, with a 2.5-fold increase in the prevalence of peritoneal dialysis patients in developing countries. The proportion of all dialysis patients treated with this modality continues to decline in developed countries.read more
Citations
More filters
Journal ArticleDOI
Changes in the worldwide epidemiology of peritoneal dialysis
Philip Kam-Tao Li,Kai Ming Chow,Moniek W.M. van de Luijtgaarden,David W. Johnson,Kitty J Jager,Rajnish Mehrotra,Sarala Naicker,Roberto Pecoits-Filho,Xueqing Yu,Norbert Lameire +9 more
TL;DR: Use of this therapy is increasing in some countries, but has proportionally decreased in parts of Europe and in Japan, and further growth in peritoneal dialysis use is required to enable this modality to become an integral part of renal replacement therapy programmes worldwide.
Journal ArticleDOI
The Current State of Peritoneal Dialysis
TL;DR: Technical innovations in peritoneal dialysis have significantly reduced therapy-related complications, allowing patients to be maintained on PD for longer periods, and the survival rate for patients treated with PD is now equivalent to that with in-center hemodialysis.
Journal ArticleDOI
Angiogenesis and Inflammation in Peritoneal Dialysis: The Role of Adipocytes
Jun Shi,Manshu Yu,Meixiao Sheng +2 more
TL;DR: Understanding the molecular mechanism, targeting changes in adipocytes and regulating adipokine secretion will help extend therapeutic methods for preventing inflammation and angiogenesis in PD.
Journal ArticleDOI
Cost of peritoneal dialysis and haemodialysis across the world
TL;DR: From the analysis, it is evident that most developed countries can provide PD at a lesser expense to the healthcare system than HD, and in most cases PD can be provided at a similar cost where economies of scale have been achieved, either by local production or by low import duties on PD equipment.
Journal ArticleDOI
Economic evaluation of dialysis therapies
TL;DR: Variations in the intrinsic costs of the available dialysis modalities as well as other factors, such as variation by country, available health-care infrastructures, the timing of dialysis initiation and renal transplantation are discussed.
References
More filters
Journal ArticleDOI
ESRD patients in 2004: global overview of patient numbers, treatment modalities and associated trends.
TL;DR: An alternative approach to reporting international ESRD-relevant data is pursued in the Dialysis Outcomes and Practice Patterns Study (DOPPS), and an extract of the latter is supplied for use and reference by renal care specialists and healthcare administrative bodies.
Journal ArticleDOI
Chronic kidney disease in the developing world.
TL;DR: The obvious task ahead for health authorities in the developing world is to detect and treat kidney disease at the earliest possible stage, writes Dr. Rashad Barsoum.
Journal ArticleDOI
How can we achieve global equity in provision of renal replacement therapy
TL;DR: Developing locally appropriate transplant programmes, effective use of nongovernmental sources of funding, service planning and cost containment, use of generic drugs and local manufacture of dialysis consumables have the potential to make life-saving renal replacement therapy available to many more in need.
Journal ArticleDOI
Healthcare systems and end-stage renal disease (ESRD) therapies—an international review: costs and reimbursement/funding of ESRD therapies
TL;DR: The costs and reimbursement patterns in the majority of countries were very similar and therefore did not explain the different distribution of modalities in these countries, and one explanation could be the difference in microeconomics, CHD being a treatment with high fixed costs, but high variable costs (supplies) and a low need for investments.
Journal ArticleDOI
Global trends in the rates of living kidney donation
TL;DR: This study shows that rates of living donor kidney transplant have steadily risen in most regions of the world, increasing its global significance as a treatment option for kidney failure.